Status:
COMPLETED
Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy
Lead Sponsor:
Yonsei University
Conditions:
Adult Patients 19 or Older Scheduled for Elective Arthroscopic Meniscectomy
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study aims to compare quality of recovery after surgery and anesthesia between patients undergoing arthroscopic meniscectomy under general anesthesia with either propofol or remimazolam based tot...
Eligibility Criteria
Inclusion
- Adult patients 19 or older, ASA class I\~III,
- scheduled for arthroscopic meniscectomy under general anesthesia and eligible for LMA use.
Exclusion
- Patient refusal,
- patients unable to read consent form, active URI or uncontrolled asthma,
- pneumonia,
- history of allergies to propofol or benzodiazepines,
- decreased liver or kidney function, heart failure of ejection fraction\<55%,
- pregnant or breastfeeding patients,
- history of substance abuse/addiction
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05280236
Start Date
March 14 2022
End Date
April 30 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea